Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bookstaver, P. B.
Nimmich, E. B.
Smith, T. J.
Justo, J. A.
Kohn, J.
Hammer, K. L.
Troficanto, C.
Albrecht, H. A.
and
Al-Hasan, M. N.
2017.
Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.
Antimicrobial Agents and Chemotherapy,
Vol. 61,
Issue. 9,
Tseng, Wen-Pin
Chen, Yee-Chun
Yang, Bey-Jing
Chen, Shang-Yu
Lin, Jr-Jiun
Huang, Ya-Huei
Fu, Chia-Ming
Chang, Shan-Chwen
and
Chen, Shey-Ying
2017.
Predicting Multidrug-Resistant Gram-Negative Bacterial Colonization and Associated Infection on Hospital Admission.
Infection Control & Hospital Epidemiology,
Vol. 38,
Issue. 10,
p.
1216.
Watkins, Richard R
and
Deresinski, Stan
2017.
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy—What Is the Clinician to Do?.
Clinical Infectious Diseases,
Vol. 65,
Issue. 12,
p.
2137.
Nimmich, Elizabeth B.
Bookstaver, P. Brandon
Kohn, Joseph
Justo, Julie Ann
Hammer, Katie L.
Albrecht, Helmut
and
Al-Hasan, Majdi N.
2017.
Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence.
Hospital Pharmacy,
Vol. 52,
Issue. 10,
p.
691.
Justo, Julie Ann
Bookstaver, P. Brandon
Kohn, Joseph
Albrecht, Helmut
and
Al-Hasan, Majdi N.
2018.
Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis.
International Journal of Antimicrobial Agents,
Vol. 51,
Issue. 3,
p.
488.
Haggard, Emily
Hagedorn, Maureen
Bookstaver, P. Brandon
Justo, Julie Ann
Kohn, Joseph
and
Al-Hasan, Majdi N.
2018.
Minimum Acceptable Susceptibility of Empirical Antibiotic Regimens for Gram-Negative Bloodstream Infections.
Infectious Diseases in Clinical Practice,
Vol. 26,
Issue. 5,
p.
283.
Carlisle, Leah
Justo, Julie Ann
and
Al-Hasan, Majdi N.
2018.
Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible Escherichia coli: A Missed Opportunity for De-Escalation of Therapy.
Antibiotics,
Vol. 7,
Issue. 4,
p.
104.
Shendi, Ali M.
Wallis, Gabriel
Painter, Helena
Harber, Mark
and
Collier, Sophie
2018.
Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single‐center experience.
Transplant Infectious Disease,
Vol. 20,
Issue. 1,
Al‐Hasan, Majdi N.
Acker, Emily C.
Kohn, Joseph E.
Bookstaver, Paul Brandon
and
Justo, Julie Ann
2018.
Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram‐Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 38,
Issue. 1,
p.
42.
Pilmis, B.
Cattoir, V.
Lecointe, D.
Limelette, A.
Grall, I.
Mizrahi, A.
Marcade, G.
Poilane, I.
Guillard, T.
Bourgeois Nicolaos, N.
Zahar, J-R.
and
Le Monnier, A.
2018.
Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
Journal of Hospital Infection,
Vol. 98,
Issue. 3,
p.
247.
Fröding, Inga
Valik, John Karlsson
Bolinder, Ludvig
Nauclér, Pontus
and
Giske, Christian G.
2019.
Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis.
International Journal of Antimicrobial Agents,
Vol. 53,
Issue. 6,
p.
820.
Al-Hasan, Majdi N.
Winders, Hana Rac
Bookstaver, P. Brandon
and
Justo, Julie Ann
2019.
Direct Measurement of Performance: A New Era in Antimicrobial Stewardship.
Antibiotics,
Vol. 8,
Issue. 3,
p.
127.
Nwafia, Ifeyinwa N.
Ohanu, Martin E.
Ebede, Samuel O.
and
Ozumba, Uchenna C.
2019.
Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria.
Annals of Clinical Microbiology and Antimicrobials,
Vol. 18,
Issue. 1,
Ben-Chetrit, Eli
Eldaim, Mustafa Abed
Bar-Meir, Maskit
Dodin, Mutaz
and
Katz, David E.
2019.
Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
International Journal of Antimicrobial Agents,
Vol. 53,
Issue. 4,
p.
423.
Kim, Moonsuk
Song, Kyoung-Ho
Kim, Chung-Jong
Choe, Pyoeng Gyun
Park, Wan Beom
Bang, Ji Hwan
Kim, Eu Suk
Park, Sang-Won
Kim, Nam Joong
Oh, Myoung-don
and
Kim, Hong Bin
2019.
Clinical Prediction Score for Community-Onset Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Species.
Journal of Korean Medical Science,
Vol. 34,
Issue. 14,
Aizawa, Yuta
Shoji, Takayo
Ito, Kenta
Kasai, Masashi
Sakurai, Hiroki
Toyofuku, Etsushi
Minami, Kisei
Hoshino, Tadashi
and
Horikoshi, Yuho
2019.
Multidrug-resistant Gram-negative Bacterial Bloodstream Infections in Children’s Hospitals in Japan, 2010–2017.
Pediatric Infectious Disease Journal,
Vol. 38,
Issue. 7,
p.
653.
Mediwala, Krutika N.
Kohn, Joseph E.
Bookstaver, P. Brandon
Justo, Julie Ann
Rac, Hana
Tucker, Kendall
Lashkova, Lora
Dash, Sangita
and
Al-Hasan, Majdi N.
2019.
Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents.
American Journal of Infection Control,
Vol. 47,
Issue. 11,
p.
1284.
Aslan, Abdullah Tarık
and
Akova, Murat
2019.
Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options.
Expert Review of Anti-infective Therapy,
Vol. 17,
Issue. 12,
p.
969.
Ramsey, Elizabeth G.
Royer, Julie
Bookstaver, P. Brandon
Justo, Julie Ann
Kohn, Joseph
Albrecht, Helmut
and
Al-Hasan, Majdi N.
2019.
Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates.
International Journal of Antimicrobial Agents,
Vol. 54,
Issue. 1,
p.
1.
Sousa, Adrian
Pérez-Rodríguez, María Teresa
Suarez, Milagros
Val, Nuria
Martínez-Lamas, Lucia
Nodar, Andrés
and
Crespo, Manuel
2019.
Validation of a clinical decision tree to predict if a patient has a bacteraemia due to a β-lactamase producing organism.
Infectious Diseases,
Vol. 51,
Issue. 1,
p.
32.